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Abstract*
Based on the everyday observations that individual human beings vary significantly in their capacity to combat death, we adopt a so-called frailty model
of human mortality. This frailty model assumes that each individual in a given
population is endowed with his or her own frailty index, r, which remains constant for life. In addition, we assume that the individual's force of mortality
(hazard rate function) at age x, /Jx(r), satisfies /Jx(r) = r/Jx where /Jx is the
population's base force of mortality at age x. Given the probability distribution
of the frailty index among the newborns in the population, an expression is
given for the distribution of the frailty index among the survivors reaching age
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x in the population. Finally, assuming that (i) the rate of mortality improvement for any age is proportional to the average frailty level of the indiViduals
at that age, (ii) a gamma distribution for the frailty index, and (iii) a Gompertz
form for the population's base force of mortality, we graduate (smooth) the observed mortality improvement factors in the published Society of Actuaries'
GAR-94 Table.

Key words and phrases: force of mortality, hazard rate, gamma distribution,
Gompertz law

1 A Review of Actuarial Mortality Projection
Throughout most of the twentieth century (except during periods of
famine, war, and other civil strife), there has been a long and consistent
trend of mortality improvement. Lancaster (1990, Chapter 3.6, Table
3.6.1) shows the persistent decline in the overall mortality in several
western countries. The reason for this decline is largely because of
improvements in public health, improvements in the production and
distribution of food, and advances in medicine and technology.
Interestingly, Vaupel and Yashin (1987, pp. 123) note that progress
in reducing mortality can be conceived in two ways. Demographers
generally view mortality change as change in the force of mortality and
associated life table statistics for a population. Most relative laypersons, on the other hand, especially physicians and other health and
safety personnel, perceive a reduction in mortality as being achieved
by saving the lives of individuals faced with death. A demographer
might report that the force of mortality at age fifty among U.S. males
was cut in half from 1900 to 1980, from 1.6 percent to 0.8 percent.
A public health specialist might focus attention on the lives that were
saved in 1980 compared with 1900 because of new surgical and medical procedures, the introduction of penicillin, polio vaccines, and other
pharmaceuticals, better nutrition and sanitation, improved automotive
safety, a decrease in cigarette smoking, faster and more effective ambulance service, and so on.
Actuaries, like demographers, generally view mortality change as
change in the force of mortality and associated life table statistics for a
population. In fact, the projection of mortality improvement has been
an important subject to actuaries. For example, in the first issue of the
Transactions of the Society of Actuaries Jenkins and Lew (1949) give a
lengthy discussion on this subject. Over the past few decades, various methods have been suggested by actuaries and demographers to
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project age-specific mortality rates. Pollard (1987) gives an excellent
review of these methods. We only summarize methods adopted by actuaries in North America and the United Kingdom in the projection of
future mortality rates.

1.1

The American Approach

The Society of Actuaries 1994 Group Annuity Reserving Table (GAR94) 1 has adopted a generation life table approach to project mortality
improvement.
Let qI be the mortality rate observed at age x in calendar year z.
Mortality improvement implies that the mortality rates for age x in
future years form a non-increasing sequence in z. In the GAR-94 Table
this implies that:

Let AAI denote the annual improvement factor in the mortality rate for
age x from calendar year z to z + 1, i.e.,

AA~

z+l
=

1- q\ .
qx

The GAR-94 Table assumes that at each age the AAI
as z increases:

=

AA x , a constant,

q1995
q1996
q1997
1994 = 1995 = 1996 = ... = 1 - AAx.
qx
qx
qx

(1)

To produce the mortality rate for a person age x in year (1994 + n), the
following formula is used:

(2)
To assist in mortality projections using equation (2), the Society of
Actuaries published the 1994 mortality rates as the base table, coupled
with the improvement factors AAx. Some values of qx and AAx for
IThe 1994 Group Annuity Mortality Table and the 1994 Group Annuity Reserving
Table are published by the Society of Actuaries Group Annuity Valuation Table Task
Force in Transactions of the Society of Actuaries, 47 (1995): 865-913.
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males at ages x = 50, ... ,99 are listed in Table 1 (where the values of
qx contain no margin). Specifically, Table 1 is an extract of the Society of
Actuaries 1994 Group Annuity Reserving Table (the SOA GAR-94 Table)
with: (i) base mortality rates qx, (ii) improvement factors AA x , and (iii)
implied rate of improvement Ex.

1.2

The British Approach

Based on the mortality experience in the United Kingdom, British
actuaries have developed a more sophisticated method of projecting
mortality.2 Using the 1980 mortality rates as the base table, continuing
improvement in mortality beyond 1980 is modeled as:
q~ = q1980 {a(x) + [1- a(x)](O.4)Z-~680},

(3)

where z is the calendar year, and
0.5,
a(x) =

x-10

{

1100'

x < 60
60::s; x::s; 110
x> 110.

(4)

Note that
lim qZ = a(x)q1980,
z-oo x
x
and
AA z

x

z+I-1980

=

1 _ a(x) + [1 - a(x)](0.4)-2-0a(x)

z-\980

+ [1- a(x)](O.4)------ZO

(5)

is a decreasing function of z.
Equation (3) has three characteristics: (i) mortality improvement declines with advancing age; (ii) the mortality rate declines exponentially
with the passage of time to a long-term limiting value; and (iii) the mortality improvement exhibits a decelerating trend.
2See Continuous Mortality Investigation Bureau (CMIB). "Standard Tables of Mortality Based on the 1979-82 Experiences." Continuous Mortality Investigation Reports, 10
(1990): 1-138.
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x
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
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Table 1
Excerpt of the Society of Actuaries'
Male 1994 Group Annuity Reserving Table (SOA GAR-94)
x
AAx
qx
AAx
qx
Ex
Ex
0.002773 0.018 0.01802
75 0.040012 0.014
0.01429
0.003088 0.019 0.01903
76 0.043933 0.014
0.01431
0.003455 0.020 0.02003
77 0.048570 0.013
0.01332
78 0.053991 0.012
0.003854 0.020 0.02004
0.01234
0.004278 0.020 0.02004
79 0.060066 0.011
0.01134
0.004758 0.019 0.01904
0.01035
80 0.066696 0.010
0.005322 0.018 0.01805
81 0.073780 0.009 0.009351
0.006001 0.017 0.01705
82 0.081217 0.008 0.008346
0.006774 0.016 0.01605
83 0.088721 0.008 0.008380
0.007623 0.016 0.01606
84 0.096358 0.007 0.007364
0.008576 0.016 0.01607
85 0.104559 0.007 0.007398
0.009663 0.015 0.01507
86 0.113755 0.007 0.007437
0.010911 0.015 0.01508
87 0.124377 0.006 0.006414
0.012335 0.014 0.01409
88 0.136537 0.005 0.005384
0.013914 0.014 0.01410
89 0.149949 0.005 0.005427
0.015629 0.014 0.01411
90 0.164442 0.004 0.004380
0.017462 0.013 0.01311
91 0.179849 0.004 0.004422
0.019391 0.013 0.01313
92 0.196001 0.003 0.003351
0.021354 0.014 0.01415
93 0.213325 0.003 0.003389
0.023364 0.014 0.01416
94 0.231936 0.003 0.003432
0.025516 0.015 0.01519
95 0.251189 0.002 0.002319
0.015
0.027905
0.01521
96 0.270441 0.002 0.002350
0.030625 0.015 0.01523
97 0.289048 0.002 0.002383
0.033549 0.015 0.01525
98 0.306750 0.001 0.001207
0.036614 0.015 0.01528
99 0.323976 0.001 0.001224
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1.3 The Frailty Approach
Most actuarial and demographic techniques for projecting mortality
rates are based on the extrapolation of past mortality rates. Few mathematical formulations are based on the underlying biological mechanism
of mortality improvement.
Traditional life table methods, after accounting for factors such as
race, gender, and smoking status, implicitly assume that the population is homogeneous, an assumption that is usually unrealistic. Empirical evidence shows that the following factors significantly affect mortality rates: genetics, economic status, education, marital status, and
lifestyle. If mortality is not classified according to these additional risk
factors, then the group's mortality characteristic will be heterogeneous.
For practical reasons not all of the above risk factors are usually included in mortality estimates. Thus, it is important to examine the consequences of heterogeneity when interpreting observed mortality rates
and mortality improvements (Vaupel et al., 1979; Hougaard, 1991). A
formal mathematical account of the treatment of heterogeneity can be
found in Hougaard (1984,1995) and the text of Namboodiri and Suchindran (1987).
Vaupel et al. (1979) propose a frailty model to study the effect of
heterogeneity on cohort mortality rates. 3 In their model, each individual in a given population is endowed with his or her intrinsic frailty
index, r, which is assumed to remain constant for life. An individual
age x with frailty index r has force of mortality (hazard rate function),
Ilx(r), which is assumed to satisfy
Ilx(r) = rll(x)

(6)

where Ilx is the population's base force of mortality at age x. Weak
(strong) individuals are associated with high (low) values of r.

2

Measurement of Mortality Improvement

To facilitate an easier discussion of mortality improvements, the
following notational style is used:
3This frailty model can be viewed as a special version of the Cox (1972) proportional
hazard model in the context of an unobserved covariate. Norberg (1989) uses a proportional hazard model for the heterogeneity in group life insurance. Two early actuarial
applications of the frailty model that merit mentioning are Redington (1969) where
there is a range of sample calculations, and Beard (1971) where the Gamma-Gompertz
model is analysed.
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• x denotes the current age and is placed at the right subscript;
• z denotes the current calendar year and is placed at the right superscript;
• A bar (-) placed on top of a quantity indicates that it is for a group
of individuals; and
• A hat () placed on top of a quantity indicates that it is the estimated or observed value.
For example, fJ.~ represents the estimated or observed hazard rate for
an individual at age x, at calendar time z.
Customary measures of progress in mortality consider only changes
in mortality rates q~ over different calendar years. Vaupel et al. (1979)
argue that this may not be the most informative measure for mortality improvement. Instead of measuring progress in terms of mortality
rates, Vaupel et al. state that it may be more appropriate to measure
such progress in terms of the hazard rate (force of mortality) for standard individuals. Vaupel et al. (1979) give two main reasons:
1. For the frailty model of equation (6), the ratio of the Ji'S measures

mortality progression at any level of frailty because the ratio is
independent of r:
Ji~+n(r')

JiYc(r') .

However, this is not true for the ratio of the q's, i.e., the ratio
depends on r:

2. In youth and middle age, when Jix and qx are close to zero, Jix
is approximately equal to qx. At the elderly ages, however, Jix,
which is not bounded by 1, can greatly exceed qx. As a result,
progress that substantially reduces Jix may have much less effect
on qx. For example, consider a reduction in Jix from 2 to 1: if
these values of Jix stayed constant over the course of a year, qx
would only be reduced from 0.86 to 0.63.
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For an integer age x, we define annual improvement factors
terms of hazard rates
EZ

1 (1 -2+1)
= 1 _ -z+1
11 x+O.5 = 1 _ og - qx
7l~+O.5

x

log (1 - q~)

E; in
(7)

where a constant hazard rate function is assumed for the age interval
(x,x + 1).
In the GAR-94 Table, the improvement factor AAx is measured by
the ratio of the observed mortality rates:
(8)

The implied improvement factor £1994 is

£1994
x

=

I_log[I- £11994 (I-AAx )]
log[I _ £11994]

(9)

Table 1 shows the values of £1994 for comparison with the values of
AAx. From Table I, one can see that the values of £1994 do not deviate
much from AAx for ages below 85. However, the relative difference becomes significant beyond age 85 and may affect our estimate of annuity
costs (as they are based on mortality projections many years into the
future).

3 A Mathematical Model for Frailty
3.1

The Basic Model

Consider a cohort of newborns (age exactly 0) where their survival
capacity varies across individuals. A standard newborn is one whose
future lifetime, X, has a force of mortality I1x and cumulative force of
mortality

Hx

=

f:

I1t dt .

(10)

Each individual has his/her unknown constant frailty index r with force
of mortality given in equation (6). Thus a standard newborn has r = 1.
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To model the heterogeneity of frailty for the cohort of newborns age
exactly 0, let Ro be the unknown frailty index of an individual chosen at
random from the cohort of newborns. Assume that Ro has a probability
density function (pdf) Bo(r) for r > 0.
For a newborn with frailty r, the (conditional) survivor function and
(conditional) pdf are:
Pr[X> xlRo = r]
j(xlr)

The joint density of X and Ro is

and the unconditional probability of a newborn chosen at random surviving to age x is
Pr[X> x]

S(x)

fo"o S(xlr) Bo(r)dr
fooo e- rHx Bo(r)dr
Mgo(-Hx},

where

MgO (8)

(11)

is the moment generating function Ro, i.e.,
oo
rB
Mgo(8) = E[e BRO ] = fo e- Bo(r)dr.

From S(x) we can get j(x), the pdf of X,
j(x) = J.1x fooo re- rHx Bo(r)dr,

(12)

and Jix, the force of mortality associated with S (x),

(13)
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Next we turn our attention to the survivors age exactly x from the
cohort of newborns. Clearly the distribution of the frailty index among
these survivors will not necessarily be the same as at age 0 because
one would expect more of the weaker ones to have died earlier. So
the population at age x should have a larger percentage of stronger
individuals.
Let Rx be the frailty variable for the survivor cohort at age x chosen
at random. Rx has pdf Bx(r) given by
rHx
Bx(r) = S(x!r)Bo(r) = eBo(r).
S(x)
Mgo(-Hx)

(14)

Thus the average frailty for the survivor cohort at age x is
oo

Rx

= E[R x ] = fo re-

rHx

Bo (r)dr
Mgo(-Hx)

= Tix
J1x

(15)

Note that Tix = J1xRx, i.e., the force of mortality for [X > x] is always
equal to the force of mortality of the standard individual multiplied by
the average frailty among the survivors.
Among those who die at age x (Le., in (x, x + dx)), the frailty index
has a conditional density:
j(x, r)
r e- rHx Bo(r)
j(x) = fooore-rHxBo(r)dr'

3.2

(16)

Gamma Frailty Density

Because of its mathematical tractability and its flexible shape, the
gamma distribution has been used by many authors (including Vaupel
et al., 1979) to model the frailty variable. Specifically we assume that
Ro has a gamma density:
(17)
where ()( > -1 is a shape parameter and f3 > 0 is a scale parameter. The
moment generating function is

Mgo((J) =

(f3 ~

e) ()(

231

Wang and Brown: A Frailty Model

The first two moments of Ro are:
-

()(

Ro

= E[Ro] = Ii'

2

and

(J

()(

(Ro) = f32'

From equation (14) Rx is also gamma distributed with shape parameter ()( and a different scale parameter f3 + Hx·
In this case, the mean frailty of the survivors at age x is
-

()(

Rx

=

f3 + Hx'

From equation (16), the frailty index for those who die in (x, x + dx)
has a conditional density that is also gamma distributed, with a shape
parameter ()( + 1 and a scale parameter f3 + Hx. In this case, the mean
frailty of those who die is:
()(+1
Rxx--,
()(

which is greater than the mean frailty of the survivors.

3.3 Gompertz's Law
Assume that the standard individual's lifetime follows Gompertz's
law:
J.lx

bc x log(c),

=

Hx

=

b(c X

-

1).

(18)

Gompertz's law has been used by actuaries since 1825. Several biological theories of aging have been developed that imply a Gompertz form
of hazard rates (see Strehler, 1977, Chapter 5). Brillinger (1961) argues
that if the human body is considered as a series system of independent
components, then the hazard rate function may follow the Gompertz
law (also see Carriere, 1992).
If the frailty variable Ro is assumed to have a gamma density in equation (17), then the birth cohort has an unconditional survivor function
-

S(x) =

(

f3
f3 + b(c X

-

1)

)iX

,

232

Journal of Actuarial Practice, Vol. 6, 1998

and hazard rate function
_
()( b eX log(e)
/-Lx = {3 + b(e X - 1)'

(19)

Equation (19) is derived in the manner used by Beard (1971), and is one
of the "laws" of mortality originally proposed by Perks (1932).
Pollard (1980,1993) studies the case where each individual in a population has a hazard rate function of the Gompertz type. Note that the
cohort hazard rate function in equation (19) increases exponentially initially, but the growth rate decreases with advancing age. Pollard points
out that this is a phenomenon observed in many populations.
Among the survivors age x, Rx has a gamma distribution with a
shape parameter ()( and a scale parameter {3 + b(e X - 1). The mean
frailty for the survivors age x is
Rx

4

()(

=

-{3-+-b-(-eX ---1-)'

A Model for Mortality Improvement

In a given calendar year, the overall level of mortality improvement
depends on the marginal changes of many external factors such as medical technology and its availability to the general public. In general, projection of these external factors for future years is a difficult task and
requires more detailed (perhaps non-actuarial) investigation. In this paper we are concerned mainly with the rates of mortality improvement
among different cohorts in a given calendar year, where the same underlying external factors apply to all ages.
We hypothesize that mortality improvements due to the marginal
advancement of life-saving techniques progress as follows:

Hypoyhesis 1. For each age x the rate of improvement in terms of the

force of mortality (hazard rate) is proportional to the average frailty Rx.
This hypothesis is based on the argument that marginal improvements in life-saving techniques have relatively larger effect on frailer
individuals with higher than average values of r. Most deaths of strong
individuals with lower than average values of r are due to natural aging;
thus, improvements in life-saving techniques or better health-practices
would have relatively smaller effects on healthier individuals, Le., those
with lower than average values of r.
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Assume that, for each birth cohort at time y, frailty has a gamma
density with:
where ()(

=

{3.

If we assume Gompertz mortality for a standard individual, the mean
frailty of the survivors at age x, at calendar time z = y + x, is

RZ
x

=

()(

()(

+ b (eX -

1)

Based on the above hypothesis, the improvement factor E~ is proportional to the average frailty of the survivor cohort at age x:
Z
-z
Ex = K R x +O.5 = K ()(

()(

+ b(ex+O.5 _ 1)'

(20)

where K is a constant, and an adjustment of a half year is used because
E~ is measured by the ratios of mid-year hazard rates.
Equation (20) of E~ implies that, at any fixed calendar time, the mortality improvement decreases rapidly at advanced ages, due to the exponential growth in Hx = b(e X - 1) with age.

5

Fitting the Gamma-Gompertz Model

Now we will fit the Gamma-Gompertz model to the GAR-94 Base Table, which gives the cohort age-specific mortality rates. Neither frailty
nor heterogeneity was discussed in the GAR-94 Table. Specifically, we
assume Gompertz's law for each individual's force of mortality.
Suppose that the cohort is homogeneous and each individual's lifetime follows the Gompertz law with f.lx = B eX. We would expect that
e[x] = [f.lX+20.5]io
f.lx+O.5

be approximately constant.
From the GAR-94 mortality rates, we have calculated the values of
e[x] at different ages (see Table 2). As shown in Table 2, the values
of e[x] exhibit a gradual decreasing trend as age increases. Although
there are many possible explanations to this observed pattern, we will
try to fit the mortality rates to a frailty (heterogeneous) model.
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Table 2
Calculated Values of c[x]

5.1

x

c[x]

x

c[x]

50
51
52
53
54
55
56
57
58
59

1.1180
1.1171
1.1160
1.1151
1.1142
1.1133
1.1124
1.1114
1.1107
1.1102

60
61
62
63
64
65
66
67
68
69

1.1097
1.1088
1.1076
1.1059
1.1040
1.1023
1.1010
1.1005
1.1006
1.1012

Fitting the 1994 Base Mortality Rates

Based on considerations that mortality rates at advanced ages may
not be as accurate due to smaller sample sizes, we suggest using some
representative age range, say, from 50 to 75. For many populations,
from the mortality rates at ages 50 and 70, one can get a good approximation of the shape of the mortality curve at all ages (Benjamin, 1982;
Pollard, 1991 and 1993).
We assume that the standard force of mortality follows the Gompertz law with
/lx = bc x log(c),

Hx = b(c X

-

1).

Furthermore, we will choose /lx such that Ro = 1.
We define a measure for goodness of fit by using the sum of squared
errors for ages from 50 to 75:
75

DIST50:75 =

I

x=50

where

(71x+o.5 - /1x+O.5)2
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can be obtained from the mortality rates in Table 1.
Assume that Ro has a gamma density, then Ro = 1 implies 0<
that

=

o<bc x log(c)
JJx= 0<+b(c X -1)'
_

f3 so

(21)

By minimizing DISTso:7s, we get the following estimate of the unknown parameters:

c = 1.1248,

b = 0.66

X

10- 4 ,

0< = 1.306,

(22)

with the minimum distance being
min{DISTsO:7s}

=

0.2238 x 1O-s.

We have noticed that the estimation of parameters for the frailty
distribution (mixing density) is not very robust, depending on the age
range used in the estimation of parameters. This is a common phenomenon in many mixture models (Chan, 1995; Manton et al., 1986;
Everitt and Hand, 1981).

5.2

Fitting the GAR-94 Mortality Improvement Factors

We shall use a Gamma-Gompertz model for the 1994 base mortality
rates and adopt the particular set of estimated parameters in equation
(22) in the Gamma-Gompertz model:
c = 1.1248,

b = 0.66 X 10- 4 ,

0< = 1.306.

The frailty model of mortality improvement in equation (20) suggests
the following pattern for the improvement factors:
1.306

1994

Ex

= K

x 1.306 + 0.66 x 10- 4 x (1.1248 x +o.s - 1)'

Now we use this frailty model of mortality improvement to fit the empirical improvement factors £1994 in Table 1. We are mainly interested
in the mortality improvement at senior ages, say, 50 and above. We first
choose an age range from 50 through 95 and define a loss measure:

236

Journal of Actuarial Practice, Vol. 6, 1998

95

M50:95

=

L

(E;994 - E;994)2.

x=50

The ages below 50 are excluded because of the sudden dip in the observed improvement factors (see Figure 1) which may be a result of
other exogenous factors (e.g., aCcident, AIDS). The ages beyond 95 are
not included because of the scarcity of available data for extreme ages
95 and above.
By minimizing the loss measure M50:95, we get a least square estimate for K:
I~g (E;994) (E;994)
K =

I

95

1994

50 (Ex

)2

=

0.01769.

Table 3 compares the Gamma-Gompertz frailty model improvement
factors Ex and the empirical improvement factors Ex in the GAR-94 table. Figure 1 also displays these improvement factors. Note that in figure 1 the Exs in the GAR-94 Table do not follow a smooth pattern. Also,
there is inSignificant mortality improvement in the 25-45 age group.4
Beyond age 50 the frailty model seems to be an acceptable fit and may
provide a theoretical basis for the observed improvement factors. The
frailty model of mortality improvement has the definite advantage that
the projected mortality rates are smooth.
The choices of the age range, from 50 to 95, and the loss measure
(Le., the squared error) are arbitrary and are for illustration purposes
only. One may use other age ranges or weighted squared error, as appropriate.

6

Other Evidence

According to United Nations 1991,5 in developed countries, one half
of female and one-third of male deaths now occur after age 80. The
mortality reductions within this age range are crucial in determining
changes in life expectancy and actuarial annuity values.

4This could be attributed to extra AIDS deaths in the 25-45 age group.
sUnited Nations Demographic Yearbook 1991. New York: United Nations
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x
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74

Table 3
Mortality Improvement Rates
x
Ex
Ex
Ex
0.013520
0.017410 0.018030
75
0.017370 0.019030
76 0.013130
77 0.012720
0.017330 0.020030
0.017290 0.020040
78 0.012290
0.017240 0.020040
79 0.011840
80 0.011370
0.017180 0.019050
0.010890
0.017120 0.018050
81
82
0.010390
0.017050 0.017050
0.016980 0.016050
83 0.0098800
84 0.0093700
0.016890 0.016060
0.016800 0.016070
85 0.0088500
0.016690 0.015070
86 0.0083300
0.016580 0.015080
87 0.0078100
0.016450 0.014090
88 0.0073100
0.016310 0.014100
89 0.0068100
0.016150 0.014110
90 0.0063200
0.015980 0.013110
91 0.0058500
92 0.0054000
0.015790 0.013130
93 0.0049700
0.015580 0.014150
94 0.0045600
0.015350 0.014160
0.015100 0.015190
95 0.0041800
0.014830 0.015210
96 0.0038200
0.014530 0.015230
97 0.0034800
0.014220 0.015260
98 0.0031600
0.013880 0.015280
99 0.0028700
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Ex
0.014290
0.014320
0.013330
0.012340
0.011340
0.010350
0.0093500
0.0083500
0.0083800
0.0073600
0.0074000
0.0074400
0.0064100
0.0053800
0.0054300
0.0043800
0.0044200
0.0033500
0.0033900
0.0034300
0.0023200
0.0023500
0.0023800
0.0012100
0.0012200
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Figure 1
Mortality Improvement Factors Ex for GAR-94
And Ex for the Frailty Model
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Kannisto et al., (1994) study the reduction in mortality at advanced
ages based on a large and reliable database for 27 countries, 1960s
through 1980s. The follOwing is cited from Kannisto et al., (1994, pp.
801):

For nine countries - Austria, Belgium, England and Wales,
West Germany, France, Japan, Scotland, Sweden, and Switzerland - data are available through 1991. A glimpse at the most
recent trends is provided by calculating the annual average
rate of mortality improvement between 1982-86 and 198791 for this aggregate of nine countries. For males the rate of
improvement was 1. 7 percent for octogenarians and 1.2 percent for nonagenarians; for females the corresponding rates
were 2.5 percent and 1.6 percent.
Even though the magnitude of the mortality improvement at advanced ages is higher than those in the GAR-94 Table, the general pattern of deceleration of mortality improvement at advanced ages is consistent with our frailty model of mortality improvement.
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In a panel discussion of mortality trends, Moriyama (1967) also provides evidence that the rate of improvement in mortality rates decreases
at advanced ages.

7 Closing Comments
The main contribution of this paper is the utilization of a frailty
model to derive mathematical formulae for mortality improvement factors. As marginal advancement in life-saving techniques determines
the pace of mortality improvement, we assume that weaker individuals
are more likely to benefit from these advances than are stronger individuals. This assumption is supported in the demography literature
(Vaupel and Yashin, 1985). To project the future trend of mortality
improvement, one needs to assess carefully the future advancement in
medical technology. A major breakthrough in medical technology or an
unexpected new epidemic may have a sudden impact on the mortality
improvement.
Several authors, including Bowers et aI., (1986) and London (1985),
have discussed the importance of smoothness in mortality rates. Their
arguments for smoothness can be extended to mortality improvement
factors. Our frailty model provides useful mathematical formulae for
graduation of empirical improvement factors.
One potential shortcoming of our model is that the frailty index is
assumed to be determined at birth and remains constant for life. Intuition suggests, however, that this assumption may be overly simplistic.
In future studies, the concept of frailty may be modeled as a variable
dependent upon exogenous observable factors such as lifestyle, environment, economic status, or marital status.
We hope this paper stimulates further research on this important
subject.
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